{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:29:22Z","timestamp":1761611362608,"version":"3.37.3"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Allergy and Infectious Diseases of the National Institutes of Health","award":["UM1AI068632"],"award-info":[{"award-number":["UM1AI068632"]}]},{"name":"National Institute of Child Health"},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Ped Infect Dis"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1093\/jpids\/piu142","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T23:24:57Z","timestamp":1422487497000},"page":"131-137","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetics of Once-Daily Darunavir\/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults"],"prefix":"10.1093","volume":"5","author":[{"given":"Kajal B.","family":"Larson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim R.","family":"Cressey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram","family":"Yogev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wiznia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Jean-Philippe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobbie","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Britto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent J.","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward P.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"key":"2016051909225016000_5.2.131.1","unstructured":"PREZISTA (darunavir) [prescribing information]. Available at: http:\/\/www.prezista.com\/healthcare\/full-prescribing-information. Accessed 4 September 2013."},{"key":"2016051909225016000_5.2.131.2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282170ab1"},{"key":"2016051909225016000_5.2.131.3","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1562"},{"key":"2016051909225016000_5.2.131.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra035092"},{"key":"2016051909225016000_5.2.131.5","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.94102s10107"},{"key":"2016051909225016000_5.2.131.6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1472-8206.2003.00140.x"},{"key":"2016051909225016000_5.2.131.7","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.2.259"},{"key":"2016051909225016000_5.2.131.8","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835a9a2d"},{"key":"2016051909225016000_5.2.131.9","unstructured":"King JR , Yogev R , Wiznia A et al . Low darunavir (DRV) and etravirine (ETR) exposure when used in combination in HIV-infected children and adolescents. In: 19th Conference on Retroviruses and Opportunistic Infections. Seattle, Washington. March 5\u20138, 2012."},{"key":"2016051909225016000_5.2.131.10","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000308"},{"key":"2016051909225016000_5.2.131.11","doi-asserted-by":"publisher","DOI":"10.1002\/PHAR.1015"},{"key":"2016051909225016000_5.2.131.12","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.62"},{"key":"2016051909225016000_5.2.131.13","doi-asserted-by":"publisher","DOI":"10.1310\/hct0906-418"},{"key":"2016051909225016000_5.2.131.14","unstructured":"Kakuda TN , Green BE , Morrish G et al . Population pharmacokinetics of etravirine in HIV-1-infected treatment-experienced children and adolescents (6\u201317 years): week 24 primary analysis of the phase II PIANO trial [Abstract TULBPE026]. In: 6th International AIDS Society Conference on HIV Pathogenesis and Treatment. Rome, Italy. July 17\u201320, 2011."},{"key":"2016051909225016000_5.2.131.15","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1562"},{"key":"2016051909225016000_5.2.131.16","doi-asserted-by":"publisher","DOI":"10.2165\/10895940-000000000-00000"},{"key":"2016051909225016000_5.2.131.17","first-page":"49","article-title":"Profile of etravirine for the treatment of HIV infection","volume":"6","author":"Tseng","year":"2010","journal-title":"Ther Clin Risk Manag"},{"key":"2016051909225016000_5.2.131.18","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182364c67"},{"key":"2016051909225016000_5.2.131.19","unstructured":"INTELENCE (Etravirine) [prescribing information]. Available at: http:\/\/www.intelence.com\/hcp\/full-prescribing-information. Accessed 9 September 2013."},{"key":"2016051909225016000_5.2.131.20","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr534"},{"key":"2016051909225016000_5.2.131.21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00691-12"},{"key":"2016051909225016000_5.2.131.22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01564-09"},{"key":"2016051909225016000_5.2.131.23","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/186987"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/5\/2\/131\/7954624\/piu142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T22:24:53Z","timestamp":1503613493000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article-lookup\/doi\/10.1093\/jpids\/piu142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,5,19]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1093\/jpids\/piu142"],"URL":"https:\/\/doi.org\/10.1093\/jpids\/piu142","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"type":"print","value":"2048-7193"},{"type":"electronic","value":"2048-7207"}],"subject":[],"published":{"date-parts":[[2015,1,28]]}}}